PTPRC and neoplasm: Figure 5 displays the flow cytometric analysis of cells in the tumour (Figure 5A,B) and the distinct immune and non‐immune cell populations, CD45+ (Figure 5C,D) and CD45− (Figure 5E,F), respectively.